PMC:7029759 / 1517-1681 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"29","span":{"begin":72,"end":76},"obj":"Gene"},{"id":"30","span":{"begin":120,"end":124},"obj":"Gene"},{"id":"47","span":{"begin":152,"end":161},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Gene:59272"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Gene:59272"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lso helping to recruit the immune system to build lasting immunity. The ACE2-Fc therapy would also supplement decreased ACE2 levels in the lungs during infection, t"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T9","span":{"begin":27,"end":40},"obj":"UBERON:0002405"},{"id":"T8","span":{"begin":72,"end":76},"obj":"G_3;PG_10;PR:000003622"},{"id":"T7","span":{"begin":120,"end":124},"obj":"G_3;PG_10;PR:000003622"},{"id":"T6","span":{"begin":139,"end":144},"obj":"UBERON:0000170"}],"text":"lso helping to recruit the immune system to build lasting immunity. The ACE2-Fc therapy would also supplement decreased ACE2 levels in the lungs during infection, t"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":27,"end":40},"obj":"Body_part"},{"id":"T7","span":{"begin":139,"end":144},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma9825"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma68877"}],"text":"lso helping to recruit the immune system to build lasting immunity. The ACE2-Fc therapy would also supplement decreased ACE2 levels in the lungs during infection, t"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":27,"end":40},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"lso helping to recruit the immune system to build lasting immunity. The ACE2-Fc therapy would also supplement decreased ACE2 levels in the lungs during infection, t"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":152,"end":161},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"lso helping to recruit the immune system to build lasting immunity. The ACE2-Fc therapy would also supplement decreased ACE2 levels in the lungs during infection, t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":27,"end":40},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T15","span":{"begin":77,"end":79},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T16","span":{"begin":139,"end":144},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"lso helping to recruit the immune system to build lasting immunity. The ACE2-Fc therapy would also supplement decreased ACE2 levels in the lungs during infection, t"}